DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Abraham NS, Singh S, Alexander GC. , et al.
Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.
BMJ 2015;
350 (02) h1857-h1857
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.